United States
Germany
Japan
United Kingdom
China
Products
Recombinant Anti-MUC1 (Clone Mc5)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-MUC1 (Clone PAM4)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
Recombinant Anti-MUC1 (Clone HMFG1 (1.10.F3))
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Human |
Recombinant Anti-MUC1 (Clone HMFG1 (1.10.F3))
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Human |
Anti-MUC1 Reference Antibody (clivatuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-MUC1 Reference Antibody (gatipotuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-MUC1 Reference Antibody (AR20.5)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-MUC1 Reference Antibody (cantuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-MUC1 Reference Antibody (clivatuzumab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Recombinant Anti-MUC1 (Clone Mc5)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-MUC1 (Clone PAM4)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
Recombinant Anti-MUC1 (Clone SM3)
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
Recombinant Anti-MUC1 (Clone HMFG2)
| Applications | ELISA, IHC |
| Reactivities | Human |
